Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Randomized, Double-Blind, Placebo Controlled Dose Escalation Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Needle-free Dermal Injection to Cohorts of Adults Receiving Surgical Sternotomy Incisions

NCT01657045 is registered in ClinicalTrials.gov with SironRX Therapeutics, Inc. as lead sponsor.

NCT NCT01657045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01657045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Randomized, Double-Blind, Placebo Controlled Dose Escalation Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Needle-free Dermal Injection to Cohorts of Adults Receiving Surgical Sternotomy Incisions
Lead sponsor
SironRX Therapeutics, Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2012
Completion date
July 31, 2014
Enrollment
25 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

median sternotomy